Factsheet on serious bacterial infections (SBI), their clinical impact, and GARDP’s efforts to develop new treatments.
Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.
Changing the way antibiotics are developed and accessed.
A public-health driven model to tackle AMR.
Our latest news and resources.
Protecting people from the rise and spread of drug-resistant infections.
Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.